RNA-Seq was used to identify differentially expressed genes, and assays of cell growth, cell cycle progression, EGFR trafficking, and downstream signaling were performed.<h4>Results</h4>CASK expression was significantly elevated in early-stage NSCLC, and higher levels correlated with reduced overall and first progression survival. The gene discussed is CASK; the disease is non-small cell lung carcinoma.